Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Top of the News-lir
Subscribe today for access to
Articles and Reports
Getting Started with the FDA’s New LDT Rule
Experts explain what the phase-in process will look like—and how labs can get ahead of the game.
Transitioning the Clinical Lab
What clinical laboratory professionals need to know about healthcare provision for transgender and nonbinary patients
Point-of-care Molecular Testing Poised to Take Off
...
Already a member? Log in here
Quest Receives Emergency FDA Clearance for Zika Test
From - Laboratory Industry Report
Quest Diagnostics has received emergency clearance from the U.S. Food and Drug Administration to distribute its molecular assay for…
Invitae Greatly Expands Testing Panels, Introduces Pricing for Uninsured
...
Already a member? Log in here
Quest Sells Much of Focus Affiliate to Italian Laboratory
...
Already a member? Log in here
Bill Would Strip California of Its Authority to Regulate Laboratories
...
Already a member? Log in here
At Lab Revolution, a Call for Changing the ‘Rules of Engagement’
From - Laboratory Industry Report
Gone are the days of isolated entities and closed systems within the American healthcare industry. And as once discrete services come to extend across the…
LabCorp Purchases Outreach Business of Los Angeles-Area Hospital
From - Laboratory Industry Report
LabCorp has purchased the outreach laboratory business of a Los Angeles-area community hospital. Henry Mayo Newhall Hospital announced…
Theranos Appoints Scientific and Advisory Medical Board
From - Laboratory Industry Report
Theranos, which continues to come under fire regarding the viability of its testing platform, has just named an eight-member scientific and advisory medical board that contains luminaries from…
Sequenom to Petition U.S. Supreme Court to Regain MaterniT21 Test Patent
...
Already a member? Log in here